Next Financial Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Next Financial Group’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-89	Closed	-$1K	–	2959
2021 Q3	$1K	Hold	89	–	–	﹤0.01%	2675
2021 Q2	$1K	Hold	89	–	–	﹤0.01%	2560
2021 Q1	$1K	Hold	89	–	–	﹤0.01%	2458
2020 Q4	$1K	Buy	+89	New	+$1.04K	﹤0.01%	2304
2020 Q1	–	Sell	-59	Closed	–	–	2372
2019 Q4	$0	Hold	59	–	–	﹤0.01%	2513
2019 Q3	$1K	Hold	59	–	–	﹤0.01%	2260
2019 Q2	$1K	Hold	59	–	–	﹤0.01%	2247
2019 Q1	$1K	Hold	59	–	–	﹤0.01%	1582
2018 Q4	$1K	Hold	59	–	–	﹤0.01%	1883
2018 Q3	$1K	Buy	+59	New	+$897	﹤0.01%	1422
2017 Q1	–	Sell	-50	Closed	–	–	2230
2016 Q4	$0	Buy	+50	New	+$182	﹤0.01%	2470

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Next Financial Group's SGMO Position: Q4 2021 in Review

Next Financial Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 89 shares — an estimated $1K sold.

Next Financial Group first reported a position in SGMO in Q4 2016 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

Next Financial Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
Next Financial Group sold 89 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $1K.
Next Financial Group first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and held it in 11 quarters.
Next Financial Group's SANGAMO THERAPEUTICS INC position peaked at $1K in Q3 2021.
193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.